3 Surprisingly Underrated Stocks to Buy Right Now
Nearly everyone likes an underdog. They're the ones who don't get the respect they deserve but often deliver pleasant surprises.
Three Motley Fool contributors think they've identified a handful of healthcare stocks that are underdogs. Here's why they view Bristol Myers Squibb (NYSE: BMY), Moderna (NASDAQ: MRNA), and (NYSE: PFE) as surprisingly underrated stocks to buy right now.
David Jagielski (Bristol Myers Squibb): There are no shortage of reasons for investors to feel bearish on Bristol Myers Squibb. The top pharmaceutical company has a lot of debt on its books due to acquisitions, and there are concerns that its growth prospects won't be all that great as it loses exclusivity for multiple top drugs, including Eliquis and Opdivo.
Source Fool.com
Pfizer Inc. Stock
With 29 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 40 € there is a hugely positive potential of 53.64% for Pfizer Inc. compared to the current price of 26.04 €.